Cytokines and Genes Differentially Affected by TNF Blockers
The present invention is directed to cytokines and genes that are differentially affected by TNF blockers and the use of these genes and cytokines to help asses the TB risks of new immunosuppressive therapies, to help evaluate the effects of new TB vaccines, and to help assess TB susceptibility in persons exposed to Mycobacterium tuberculosis.
WALLIS ROBERT [US]
Type of Offer:
« More Biotech Patents